Revista espanola de cardiologia (English ed.) · 2025
Stent implantation for recurrent stenosis after aortic arch repair in small children: short- and mid-term results without reoperations.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gendera Katarzyna, Georgiev Stanimir, Eicken Andreas, Amici Andrea, Hager Alfred, von Stumm Maria, Dilber Daniel, Ewert Peter, Bambul Heck Pinar
Аннотация
INTRODUCTION AND OBJECTIVES: Stent implantation has become the gold standard for the treatment of native coarctation of the aorta (CoA) and recurrent CoA in adolescents and adults. In smaller children, however, stent implantation remains technically challenging due to anatomical constraints and growth considerations. Furthermore, data on the optimal treatment strategy in this age group are still limited. This study retrospectively analyzed clinical outcomes in young children treated with stent implantation for recurrent aortic arch stenosis.
METHODS: A total of 101 patients (63 male; 62%) with a body weight of less than 15kg were treated with endovascular stent implantation for restenosis of the reconstructed aortic arch (n=94; 93%) or native CoA (n=7; 7%). The median age at the time of stent implantation was 4.8 months (IQR, 3.2-9.6 months) with a median body weight of 5.9kg (IQR, 4.7-8.4kg). The median follow-up period was 46.4 months (IQR, 11.0-76.6 months).
RESULTS: All procedures were successful, and no serious complications occurred. The peak-to-peak gradient decreased significantly from a median of 32.5mmHg (IQR, 17.3-46.0mmHg) to 0.0mmHg (IQR, 0.0-2.5mmHg; P<.005). The diameter of the narrow segment increased from a median of 3.0mm (IQR, 2.0-4.0mm) to 6.9mm (IQR, 6.0-8.0mm; P<.005). During follow-up, none of the patients required reoperation.
CONCLUSIONS: Stent implantation is a safe and feasible treatment option in patients with restenosis after complex aortic arch reconstruction or native CoA in whom surgical treatment would pose an elevated risk of complications. However, repeated dilatations and, ultimately, intentional stent fracture are required during follow-up.
METHODS: A total of 101 patients (63 male; 62%) with a body weight of less than 15kg were treated with endovascular stent implantation for restenosis of the reconstructed aortic arch (n=94; 93%) or native CoA (n=7; 7%). The median age at the time of stent implantation was 4.8 months (IQR, 3.2-9.6 months) with a median body weight of 5.9kg (IQR, 4.7-8.4kg). The median follow-up period was 46.4 months (IQR, 11.0-76.6 months).
RESULTS: All procedures were successful, and no serious complications occurred. The peak-to-peak gradient decreased significantly from a median of 32.5mmHg (IQR, 17.3-46.0mmHg) to 0.0mmHg (IQR, 0.0-2.5mmHg; P<.005). The diameter of the narrow segment increased from a median of 3.0mm (IQR, 2.0-4.0mm) to 6.9mm (IQR, 6.0-8.0mm; P<.005). During follow-up, none of the patients required reoperation.
CONCLUSIONS: Stent implantation is a safe and feasible treatment option in patients with restenosis after complex aortic arch reconstruction or native CoA in whom surgical treatment would pose an elevated risk of complications. However, repeated dilatations and, ultimately, intentional stent fracture are required during follow-up.